2005

2005 Publications

Amon W and Farrell PJ. Reactivation of Epstein-Barr virus from latency. Reviews in Medical Virology,78: 13460-13469, 2005

Bartlett, N.W., Buttigieg, K., Kotenko, S.V. & Smith, G.L. (2005). Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. J. Gen. Virol. 86, 1589-1596.

Carter GC, Law M, Hollinshead M, Smith GL.  Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans.  J Gen Virol. 86:1279-1290, 2005.

Farrell PJ.  Mechanisms of viral carcinogenesis. In: Introduction to the Cellular and Molecular Biology of Cancer, 4th Edition. Eds M. Knowles and P. Selby, Oxford University Press, 2005.

Farrell PJ.  Epstein-Barr virus genome.  In Epstein-Barr virus, Horizon, Caister Press ed E. Roberston. 2005.

Farrell PJ. Epstein-Barr virus DNA in plasma as a marker of nasopharyngeal carcinoma. Nature Clinical Practice Oncology, 2: 14-15, 2005.

Herrero-Martinez E, Roberts KL, Hollinshead M, Smith GL. Vaccinia virus intracellular enveloped virions move to the cell periphery on microtubules in the absence of the A36R protein.  J Gen Virol. 2005 86: 2961-2968.

Law M, Putz MM, Smith GL. An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model.  J Gen Virol. 86:991-1000, 2005.

Putz MM, Alberini I, Midgley CM, Manini I, Montomoli E, Smith GL. Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy.
J Gen Virol. 2005 86: 2955-2960.

Sdek P, Ying H, Chang DL, Qiu W, Zheng H, Touitou R, Allday MJ, Xiao ZX.
MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein. Mol Cell. 20: 699-708, 2005.

Smith, G.L. (2005).  Poxviruses. In Topley & Wilson’s Microbiology and Microbial Infections. Edited by Mahy, B.H. & ter Meulen, V. Volume 1, pp 578-593.

Smith, G.L. (2005). Vaccinia virus virulence. Nova Acta Leopoldina NF 92, Nr. 344, 1-6.

Spender LC, Whiteman HJ, Karstegl CE, Farrell PJ. Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells.  Oncogene. 24:1873-1881, 2005.

Stack J, Haga IR, Schroder M, Bartlett NW, Maloney G, Reading PC, Fitzgerald KA, Smith GL, Bowie AG.  Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.  J Exp Med. 201:1007-1018, 2005.

Touitou R, O'Nions J, Heaney J, Allday MJ. Epstein-Barr virus EBNA3 proteins bind to the C8/alpha7 subunit of the 20S proteasome and are degraded by 20S proteasomes in vitro, but are very stable in latently infected B cells.  J Gen Virol. 86:1269-1277, 2005.